Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jonathan Lim, M.D.
AddedFeb 13, 2024
UpdatedMay 31, 2026
Jonathan Lim, M.D.

Jonathan Lim, M.D.

Co-Founder, Boundless Bio

CrunchbaseLinkedInThe Org

Jonathan Lim, M.D.'s Career

Boundless Bio
Boundless Bio

Los Angeles, CA, US

Co-Founder
Maze Therapeutics
Maze Therapeutics

South San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jonathan Lim, M.D.'s Career

Boundless Bio
Boundless Bio
Series C$251.4M1752018Los Angeles, CA, US
Co-Founder

Leadership at Boundless Bio

Jennifer LewJennifer LewBoard Member
Benjamin CravattBenjamin CravattCo-Founder
Zachary HornbyZachary HornbyCEO
Jakob LovenJakob LovenBoard Member

Similar to Boundless Bio

Palm TherapeuticsPalm TherapeuticsSan Diego, CA, USCancer Treatmentest. 2018Palm TherapeuticsSan Diego, CA, US · est. 2018

Revolutionizing cancer treatment with next-gen root-level therapeutics.

Angel · $991.1k7
Modifi BioModifi BioNew Haven, CT, USCancer Therapeuticsest. 2021Modifi BioNew Haven, CT, US · est. 2021

Modifi Biosciences: Pioneering DNA modification for innovative cancer therapeutics.

Seed · $13.1M34
Innovo TherapeuticsInnovo TherapeuticsSan Diego, CA, USAnti-Cancer Drugsest. 2021Innovo TherapeuticsSan Diego, CA, US · est. 2021

San Diego-based Innovo Therapeutics develops anti-cancer drugs targeting protein breakdown.

Seed · $200M11
Exovita BiosciencesExovita BiosciencesAlbuquerque, NM, USCancer Therapeuticsest. 2014Exovita BiosciencesAlbuquerque, NM, US · est. 2014

Exovita Biosciences, a biotech firm, pioneers in developing exosome-based cancer therapeutics.

Seed · $9k30
Maze Therapeutics
Maze Therapeutics
Late Stage Private$381M1352018South San Francisco, CA, US
Board Member· Board

Leadership at Maze Therapeutics

Catherine SohnCatherine SohnBoard Member
Jason ColomaJason ColomaBoard Member
Richard SchellerRichard SchellerBoard Member
Andy TranAndy TranBoard Member
Jeffrey TongJeffrey TongBoard Member
Dan SpiegelmanDan SpiegelmanBoard Member

Similar to Maze Therapeutics

Mahzi TherapeuticsMahzi TherapeuticsSan Mateo, CA, USBiotechest. 2020Mahzi TherapeuticsSan Mateo, CA, US · est. 2020

Mahzi Therapeutics: A California-based healthcare and biotech firm, founded in 2020.

Series A · $47.3M13
Encoded TherapeuticsEncoded TherapeuticsSouth San Francisco, CA, USPrecision Therapiesest. 2014Encoded TherapeuticsSouth San Francisco, CA, US · est. 2014

Encoded: Leveraging human genome power for effective precision therapies in genetic disorders.

Series D · $239.1M200
Moma TherapeuticsMoma TherapeuticsCambridge, MA, USPrecision Medicinesest. 2020Moma TherapeuticsCambridge, MA, US · est. 2020

MOMA Therapeutics, a biotech firm, is dedicated to discovering precision medicines by unlocking molecular complexities.

Series B · $236M75
Denali TherapeuticsDenali TherapeuticsSan Francisco, CA, USBiotechest. 2015Denali TherapeuticsSan Francisco, CA, US · est. 2015

Denali Therapeutics, a US-based biotech firm, develops medicines for neurodegenerative diseases.

Public · $622M427

Jonathan Lim, M.D.'s Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Jonathan Lim, M.D.

Dan RosenDan RosenCo-Founder · MosaicZurab TutberidzeZurab TutberidzeCo-Founder · BaasiScott JonesScott JonesFounder · PowerfileShalom OsiadiShalom OsiadiFounder · EscaAndres MorenoAndres MorenoBoard Member · Open English